Assessing the neonatal safety of indomethacin tocolysis: A systematic review with meta-analysis

Obstetrics and Gynecology

Volumn 106, Issue 1, 2005, Pages 173-179

  Loe, Shanan M ^a   Sanchez Ramos, Luis ^a   Kaunitz, Andrew M ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

BRAIN HEMORRHAGE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DRUG INDUCED DISEASE; HUMAN; INCIDENCE; KIDNEY MALFORMATION; LUNG DYSPLASIA; LUNG MALFORMATION; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; OBSERVATION; PATENT DUCTUS ARTERIOSUS; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TOCOLYSIS;

EID: 21244435937     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000168622.56478.df     Document Type: Review

References (60)

1. Higby K, Xenakis E, Pauerstein C. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
2. Huszar G, Naftolin F. The myometrium and uterine cervix in normal and preterm labor. N Engl J Med 1984;311:571-81.
3. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
4. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. II. Double-blind study. J Perinat Med 1984;12:25-8.
5. Keirse M. Indomethacin tocolysis in preterm labor. In: Enkin M, Keirse M, Renfrew M, Neilson J, editors. Pregnancy and childbirth module of the Cochrane Database of Systemic Reviews. London: BMJ Publishing Group; 1995.
6. Moise KJ Jr, Ou CN, Kirshon B, Cano LE, Rognerud C, Carpenter RJ Jr. Placental transfer of indomethacin in human pregnancy. Am J Obstet Gynecol 1990;162:549-54.
7. Norton M, Merrill J, Cooper B, Kuller J, Clyman R. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
8. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin: adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998;38:11-6.
9. Gardner M, Owen J, Skelly S, Hauth J. Preterm delivery after indomethacin: a risk factor for complications? J Reprod Med 1996;41:903-6.
10. Vermillion S, Newman B. Recent indomethacin tocolysis is not associated with complications in preterm infants. Am J Obstet Gynecol 1999;181:1083-6.
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Drummond R, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283: 2008-12.
12. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement. Quality of Reporting Meta-Analyses. Lancet 1999;354: 1896-1900.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997; 315:629-34.
16. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. IARC Sci Pub 1980;32:5-338.
17. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107:224-33.
18. Altman D. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-12.
19. Van Overmeire B, Slootmaekers V, De Loor J, Buytaert P, Hagendorens M, Sys S, et al. The addition of indomethacin to betamimetics for tocolysis: any benefit to the neonate? Eur J Obstet Gynecol Reprod Biol 1998;77:41-5.
20. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 2000;159:153-5.
21. Weintraub Z, Solovechick M, Reichman B, Rotschild A, Waisman D, Davkin O, et al. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2001;85:F13-7.
22. Gerson A, Abbasi S, Johnson A, Kalchbrenner M, Ashmead G, Bolognese R. Safety and efficacy of long-term tocolysis with indomethacin. Am J Perinatol 1990;7:71-4.
23. Abbasi S, Gerdes J, Sehdev H, Samimi S, Ludmir J. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol 2003;189:782-5.
24. Niebyl J, Witter F. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol 1986;155: 747-9.
25. Iannucci T, Besinger R, Fisher S, Gianopoulos J, Tomich P. Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol 1996;175:1043-6.
26. Suarez R, Grobman W, Parilla B. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol 2001;97:921-5.
27. Major C, Lewis D, Harding J, Porto M, Garite T. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth weight neonate. Am J Obstet Gynecol 1994;170:102-6.
28. Hammerman C, Glaser J, Kaplan M, Schimmel M, Ferber B, Eidelman A. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998;102:1-4.
29. Al-Alaiyan S, Seshia M, Casiro O. Neurodevelopmental outcome of infants exposed to indomethacin antenatally. J Perinat Med 1996;24:405-11.
30. Guthrie S, Gordon P, Thomas V, Thorp J, Peabody J, Clark R. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-85.
31. Parilla B, Grobman W, Holtzman R, Thomas H, Dooley S. Indomethacin tocolysis and risk of necrotizing enterocolitis. Obstet Gynecol 2000;96:120-3.
32. Bivins H, Newman R, Fyfe D, Campbell B, Stramm S. Randomized trial of oral indomethacin and terbutabline sulfate for the long-term suppression of preterm labor. Am J Obstet Gynecol 1993;169:1065-70.
33. Newton ER, Shields L, Ridgway LE, Berkus MD, Elliot BD. Combination of antibiotics and indomethacin in idiopathic preterm labor: a randomized double-blind clinical trial. Am J Obstet Gynecol 1991;165:1753-9.
34. Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol 1991;78:1093-7.
35. Panter K, Hannah M, Amankwah K, Ohlsson A, Jefferies A, Farine D. The effect of indomethacin tocolysis in preterm labor on perinatal outcome: a randomized placebo-controlled trial. Br J Obstet Gynaecol 1999;106:467-73.
36. Morales W, Smith S, Angel J, O'Brien W, Knuppel R. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989; 74:567-72.
37. Besinger R, Niebyl J, Keyes W, Johnson T. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991; 164:981-6.
38. Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994;124:782-8.
39. Parilla B, Tamura R, Cohen L, Clark E. Lack of effect of antenatal indomethacin on fetal cerebral blood flow. Am J Obstet Gynecol 1997;176:1166-9.
40. Carlan S, O'Brien W, O'Leary T, Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79:223-8.
41. Morales W, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993;169:97-102.
42. Dudley D, Hardie M. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985;151: 181-4.
43. Sibony O, de Gayffier A, Carbillon L, Oury J, Boissinot C, Germain J, et al. Has the use of indomethacin during pregnancy consequences in newborn infants? Prospective study of 83 pregnant women and 115 newborn infants. Arch Pediatr 1994;1:709-15.
44. Jacqz-Aigrain E, Guillonneau M, Boissinot C, Bavoux F, Hartmann J, Blot P. Maternal and neonatal effects of indomethacin administrated during pregnancy: apropos of 18 cases. Arch Fr Pediatr 1993;50:307-12.
45. Moise K. Effect of advancing gestational age on the frequency of fetal ductal- constriction in association with maternal indomethacin use. Am J Obstet Gynecol 1993;168:1350-3.
46. Moise K, Huhta J, Sharif D, Ou C, Kirshon B, Wasserstrum N, et al. Indomethacin in the treatment of premature labor. N Engl J Med 1988;319:327-31.
47. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and B-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991;164:141-6.
48. Vermillion S, Scardo J, Lashus A, Wiles H. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177:256-61.
49. Rasanen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: A randomized study. Am J Obstet Gynecol 1995;173:20-5.
50. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol 1990;76:689-92.
51. Sawdy R, Lye S, Fisk N, Bennett R. A double-blind randomized study of fetal side effects during and after short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. Am J Obstet Gynecol 2003;188:1046-51.
52. Suarez V, Thompson L, Jain V, Olson G, Hankins G, Belfort M, et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol 2002;187:886-8.
53. Butler-O'Hara M, D'Angio C. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J Perinatol 2002;22:541-6.
54. Katz Z, Lancet M, Yemini M, Mogilner B, Feigl A, Ben Hur H. Treatment of premature labor contraction with combined ritodrine and indomethacin. Int J Gynaecol Obstet 1983;21: 337-42.
55. Spearing G. Alcohol, indomethacin, and salbutamol. Obstet Gynecol 1979;53:171-4.
56. Salokorpi T, Eronen M, von Wendt L. Growth and development until 18 months of children exposed to tocolytics indomethacin and nydrilin. Neuropediatrics 1996;27:174-7.
57. de Veciana M, Porto M, Major CA, Barke JI. Tocolysis in advanced preterm labor: impact on neonatal outcome. Am J Perinatol 1995;12:294-8.
58. Thorp J, Jones P, Clark R, Knox E, Peabody J. Perinatal factors associated with severe intracranial hemorrhage. Am J Obstet Gynecol 2001;185:859-62.
59. Macones G, Robinson C. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 1997;177:819-24.
60. Baker S, Lindeman K, Kramer B. The paired availability design for historical controls. BMC Med Res Methodol 2001;1:9.